Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy

Clinical uncertainty exists regarding which assay should be designated as the standard monitoring coagulation test for intravenous unfractionated heparin (UFH). Several studies have compared the use of activated partial thromboplastin time (aPTT) and antifactor-Xa (anti-Xa) and have come out with va...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Appl Thromb Hemost
Autors principals: McLaughlin, Kevin, Rimsans, Jessica, Sylvester, Katelyn W., Fanikos, John, Dorfman, David M., Senna, Patricia, Connors, Jean M., Goldhaber, Samuel Z.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829967/
https://ncbi.nlm.nih.gov/pubmed/31530176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029619876030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars